Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 163 Pages
Report ld: 5342812
Request Sample
Customized Report
Dynamic Blood Glucose Meter Market Size(US$)

CAGR 2025-2031
9.3%
Market Size,2031
USD 4,919
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Dynamic Blood Glucose Meter market is projected to grow from US$ 2631 million in 2024 to US$ 4919 million by 2031, at a CAGR of 9.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
A dynamic blood glucose meter is an instrument that can monitor and view blood sugar in real time. It is mainly worn on the arms, abdomen and other parts and works through a blood glucose probe and a recorder. This instrument can continuously monitor our blood sugar changes and promptly reflect the level of blood sugar levels, thereby helping us better control blood sugar and prevent the occurrence of complications.
Diabetes is a chronic disease and there is no complete cure yet and requires long-term control of blood sugar. High blood sugar may also cause damage to the body's organs, such as the kidneys, eyes, feet, etc. These injuries may lead to serious consequences such as vision loss, renal insufficiency, amputation, etc. If blood sugar is not controlled properly, it may also lead to serious complications, such as cardiovascular disease, kidney disease, neuropathy, etc. Therefore, blood sugar issues must be taken seriously. For people with blood sugar problems, blood sugar monitoring is very important. Long-term hyperglycemia manifested by diabetes can cause serious damage to the patient's heart, blood vessels, kidneys and nerves, and therefore requires effective management and treatment. Blood glucose monitoring is conducive to clinically tracking the treatment effect of patients and timely adjusting treatment plans, which is an important part of diabetes treatment. The first thing is to use blood sugar monitoring to understand our current blood sugar status and thus evaluate the control of diabetes. Secondly, daily living habits such as diet, exercise, and emotions, as well as the impact of factors such as diseases and drugs on blood sugar, and to formulate personalized hypoglycemic plans for each person's specific situation to achieve better therapeutic effects.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Dynamic Blood Glucose Meter market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Dynamic Blood Glucose Meter study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Dynamic Blood Glucose Meter: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Dynamic Blood Glucose Meter Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Wearable
1.2.3 Implant
1.3 Market Segmentation by Application
1.3.1 Global Dynamic Blood Glucose Meter Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital Use
1.3.3 Home Use
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dynamic Blood Glucose Meter Revenue Estimates and Forecasts 2020-2031
2.2 Global Dynamic Blood Glucose Meter Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Dynamic Blood Glucose Meter Sales Estimates and Forecasts 2020-2031
2.4 Global Dynamic Blood Glucose Meter Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Dynamic Blood Glucose Meter Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Dynamic Blood Glucose Meter Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Wearable Market Size by Manufacturers
3.5.2 Implant Market Size by Manufacturers
3.6 Global Dynamic Blood Glucose Meter Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Dynamic Blood Glucose Meter Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Dynamic Blood Glucose Meter Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Dynamic Blood Glucose Meter Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Dynamic Blood Glucose Meter Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Dynamic Blood Glucose Meter Sales and Revenue by Type (2020-2031)
6.4 North America Dynamic Blood Glucose Meter Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Dynamic Blood Glucose Meter Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Dynamic Blood Glucose Meter Sales and Revenue by Type (2020-2031)
7.4 Europe Dynamic Blood Glucose Meter Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Dynamic Blood Glucose Meter Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Dynamic Blood Glucose Meter Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Dynamic Blood Glucose Meter Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Dynamic Blood Glucose Meter Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Dynamic Blood Glucose Meter Sales and Revenue by Type (2020-2031)
9.4 Central and South America Dynamic Blood Glucose Meter Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Dynamic Blood Glucose Meter Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Dynamic Blood Glucose Meter Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Dynamic Blood Glucose Meter Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Dynamic Blood Glucose Meter Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott Dynamic Blood Glucose Meter Product Models, Descriptions and Specifications
11.1.4 Abbott Dynamic Blood Glucose Meter Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Abbott Dynamic Blood Glucose Meter Sales by Product in 2024
11.1.6 Abbott Dynamic Blood Glucose Meter Sales by Application in 2024
11.1.7 Abbott Dynamic Blood Glucose Meter Sales by Geographic Area in 2024
11.1.8 Abbott Dynamic Blood Glucose Meter SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 DexCom
11.2.1 DexCom Corporation Information
11.2.2 DexCom Business Overview
11.2.3 DexCom Dynamic Blood Glucose Meter Product Models, Descriptions and Specifications
11.2.4 DexCom Dynamic Blood Glucose Meter Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 DexCom Dynamic Blood Glucose Meter Sales by Product in 2024
11.2.6 DexCom Dynamic Blood Glucose Meter Sales by Application in 2024
11.2.7 DexCom Dynamic Blood Glucose Meter Sales by Geographic Area in 2024
11.2.8 DexCom Dynamic Blood Glucose Meter SWOT Analysis
11.2.9 DexCom Recent Developments
11.3 Medtronic
11.3.1 Medtronic Corporation Information
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Dynamic Blood Glucose Meter Product Models, Descriptions and Specifications
11.3.4 Medtronic Dynamic Blood Glucose Meter Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Medtronic Dynamic Blood Glucose Meter Sales by Product in 2024
11.3.6 Medtronic Dynamic Blood Glucose Meter Sales by Application in 2024
11.3.7 Medtronic Dynamic Blood Glucose Meter Sales by Geographic Area in 2024
11.3.8 Medtronic Dynamic Blood Glucose Meter SWOT Analysis
11.3.9 Medtronic Recent Developments
11.4 Senseonics Holdings
11.4.1 Senseonics Holdings Corporation Information
11.4.2 Senseonics Holdings Business Overview
11.4.3 Senseonics Holdings Dynamic Blood Glucose Meter Product Models, Descriptions and Specifications
11.4.4 Senseonics Holdings Dynamic Blood Glucose Meter Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Senseonics Holdings Dynamic Blood Glucose Meter Sales by Product in 2024
11.4.6 Senseonics Holdings Dynamic Blood Glucose Meter Sales by Application in 2024
11.4.7 Senseonics Holdings Dynamic Blood Glucose Meter Sales by Geographic Area in 2024
11.4.8 Senseonics Holdings Dynamic Blood Glucose Meter SWOT Analysis
11.4.9 Senseonics Holdings Recent Developments
11.5 Glucotrack, Inc.
11.5.1 Glucotrack, Inc. Corporation Information
11.5.2 Glucotrack, Inc. Business Overview
11.5.3 Glucotrack, Inc. Dynamic Blood Glucose Meter Product Models, Descriptions and Specifications
11.5.4 Glucotrack, Inc. Dynamic Blood Glucose Meter Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Glucotrack, Inc. Dynamic Blood Glucose Meter Sales by Product in 2024
11.5.6 Glucotrack, Inc. Dynamic Blood Glucose Meter Sales by Application in 2024
11.5.7 Glucotrack, Inc. Dynamic Blood Glucose Meter Sales by Geographic Area in 2024
11.5.8 Glucotrack, Inc. Dynamic Blood Glucose Meter SWOT Analysis
11.5.9 Glucotrack, Inc. Recent Developments
11.6 Medtrum Technologies
11.6.1 Medtrum Technologies Corporation Information
11.6.2 Medtrum Technologies Business Overview
11.6.3 Medtrum Technologies Dynamic Blood Glucose Meter Product Models, Descriptions and Specifications
11.6.4 Medtrum Technologies Dynamic Blood Glucose Meter Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Medtrum Technologies Recent Developments
11.7 Roche
11.7.1 Roche Corporation Information
11.7.2 Roche Business Overview
11.7.3 Roche Dynamic Blood Glucose Meter Product Models, Descriptions and Specifications
11.7.4 Roche Dynamic Blood Glucose Meter Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Roche Recent Developments
11.8 I-SENS
11.8.1 I-SENS Corporation Information
11.8.2 I-SENS Business Overview
11.8.3 I-SENS Dynamic Blood Glucose Meter Product Models, Descriptions and Specifications
11.8.4 I-SENS Dynamic Blood Glucose Meter Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 I-SENS Recent Developments
11.9 AgaMatrix
11.9.1 AgaMatrix Corporation Information
11.9.2 AgaMatrix Business Overview
11.9.3 AgaMatrix Dynamic Blood Glucose Meter Product Models, Descriptions and Specifications
11.9.4 AgaMatrix Dynamic Blood Glucose Meter Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 AgaMatrix Recent Developments
11.10 Sinocare
11.10.1 Sinocare Corporation Information
11.10.2 Sinocare Business Overview
11.10.3 Sinocare Dynamic Blood Glucose Meter Product Models, Descriptions and Specifications
11.10.4 Sinocare Dynamic Blood Glucose Meter Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Sinocare Recent Developments
11.11 Huzhou Meiqi Medical Instruments
11.11.1 Huzhou Meiqi Medical Instruments Corporation Information
11.11.2 Huzhou Meiqi Medical Instruments Business Overview
11.11.3 Huzhou Meiqi Medical Instruments Dynamic Blood Glucose Meter Product Models, Descriptions and Specifications
11.11.4 Huzhou Meiqi Medical Instruments Dynamic Blood Glucose Meter Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Huzhou Meiqi Medical Instruments Recent Developments
11.12 Zhejiang POCTech Corporation
11.12.1 Zhejiang POCTech Corporation Corporation Information
11.12.2 Zhejiang POCTech Corporation Business Overview
11.12.3 Zhejiang POCTech Corporation Dynamic Blood Glucose Meter Product Models, Descriptions and Specifications
11.12.4 Zhejiang POCTech Corporation Dynamic Blood Glucose Meter Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Zhejiang POCTech Corporation Recent Developments
11.13 MicroTech Medical
11.13.1 MicroTech Medical Corporation Information
11.13.2 MicroTech Medical Business Overview
11.13.3 MicroTech Medical Dynamic Blood Glucose Meter Product Models, Descriptions and Specifications
11.13.4 MicroTech Medical Dynamic Blood Glucose Meter Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 MicroTech Medical Recent Developments
11.14 SIBIONICS
11.14.1 SIBIONICS Corporation Information
11.14.2 SIBIONICS Business Overview
11.14.3 SIBIONICS Dynamic Blood Glucose Meter Product Models, Descriptions and Specifications
11.14.4 SIBIONICS Dynamic Blood Glucose Meter Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 SIBIONICS Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Dynamic Blood Glucose Meter Industry Chain
12.2 Dynamic Blood Glucose Meter Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Dynamic Blood Glucose Meter Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Dynamic Blood Glucose Meter Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Dynamic Blood Glucose Meter Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Dynamic Blood Glucose Meter Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Dynamic Blood Glucose Meter market was valued at US$ 2885 million in 2025 and is anticipated to reach US$ 5331 million by 2032, at a CAGR of 9.3% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 125
USD 2900.00
(Single User License)
The global Dynamic Blood Glucose Meter market size was US$ 2885 million in 2025 and is forecast to reach a readjusted size of US$ 5331 million by 2032 with a CAGR of 9.3% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 92
USD 4250.00
(Single User License)
The global market for Dynamic Blood Glucose Meter was estimated to be worth US$ 2885 million in 2025 and is projected to reach US$ 5331 million, growing at a CAGR of 9.3% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 129
USD 3950.00
(Single User License)
The global Dynamic Blood Glucose Meter market is projected to grow from US$ 2885 million in 2025 to US$ 5331 million by 2032, at a CAGR of 9.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-01-09
Pages: 169
USD 4900.00
(Single User License)
The global Dynamic Blood Glucose Meter market size was US$ 2631 million in 2024 and is forecast to a readjusted size of US$ 4919 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 92
USD 4250.00
(Single User License)
The global market for Dynamic Blood Glucose Meter was estimated to be worth US$ 2631 million in 2024 and is forecast to a readjusted size of US$ 4919 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published Date: 2025-06-29
Pages: 122
USD 3950.00
(Single User License)
The global Dynamic Blood Glucose Meter market is projected to grow from US$ 2885 million in 2025 to US$ 4919 million by 2031, at a Compound Annual Growth Rate (CAGR) of 9.3% during the forecast period.
Published Date: 2025-06-29
Pages: 164
USD 4900.00
(Single User License)
The global market for Dynamic Blood Glucose Meter was valued at US$ 2631 million in the year 2024 and is projected to reach a revised size of US$ 4919 million by 2031, growing at a CAGR of 9.3% during the forecast period.
Published Date: 2025-06-29
Pages: 95
USD 2900.00
(Single User License)
The global market for Dynamic Blood Glucose Meter was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 120
USD 3950.00
(Single User License)
Although small, CGM can improve the quality of life of millions of diabetes patients worldwide. For example, in patients with Type 1 diabetes, the current routine method is fingertip blood sampling to detect blood sugar, which is essential every day. In fact, fingertip blood collection can only occur up to 7 times a day. But this can only obtain a single point in time snapshot of blood sugar. Unfortunately, this snapshot can only provide blood glucose values for a specific period of time, and cannot provide all-weather blood glucose values for diabetes patients. Diabetes patients also can not obtain the overall changes in blood glucose and the reasons for the changes, so they can not develop targeted sugar control programs in line with specific individuals, including diet, medication, exercise, etc.
Published Date: 2024-04-15
Pages: 110
USD 4900.00
(Single User License)
The global Dynamic Blood Glucose Meter market was valued at US$ 2885 million in 2025 and is anticipated to reach US$ 5331 million by 2032, at a CAGR of 9.3% from 2026 to 2032.
Published: 2026-04-17
Pages: 125
The global Dynamic Blood Glucose Meter market size was US$ 2885 million in 2025 and is forecast to reach a readjusted size of US$ 5331 million by 2032 with a CAGR of 9.3% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 92
The global market for Dynamic Blood Glucose Meter was estimated to be worth US$ 2885 million in 2025 and is projected to reach US$ 5331 million, growing at a CAGR of 9.3% from 2026 to 2032.
Published: 2026-03-06
Pages: 129
The global Dynamic Blood Glucose Meter market is projected to grow from US$ 2885 million in 2025 to US$ 5331 million by 2032, at a CAGR of 9.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-01-09
Pages: 169
The global Dynamic Blood Glucose Meter market size was US$ 2631 million in 2024 and is forecast to a readjusted size of US$ 4919 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 92
The global market for Dynamic Blood Glucose Meter was estimated to be worth US$ 2631 million in 2024 and is forecast to a readjusted size of US$ 4919 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published: 2025-06-29
Pages: 122
The global Dynamic Blood Glucose Meter market is projected to grow from US$ 2885 million in 2025 to US$ 4919 million by 2031, at a Compound Annual Growth Rate (CAGR) of 9.3% during the forecast period.
Published: 2025-06-29
Pages: 164
The global market for Dynamic Blood Glucose Meter was valued at US$ 2631 million in the year 2024 and is projected to reach a revised size of US$ 4919 million by 2031, growing at a CAGR of 9.3% during the forecast period.
Published: 2025-06-29
Pages: 95
The global market for Dynamic Blood Glucose Meter was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 120
Although small, CGM can improve the quality of life of millions of diabetes patients worldwide. For example, in patients with Type 1 diabetes, the current routine method is fingertip blood sampling to detect blood sugar, which is essential every day. In fact, fingertip blood collection can only occur up to 7 times a day. But this can only obtain a single point in time snapshot of blood sugar. Unfortunately, this snapshot can only provide blood glucose values for a specific period of time, and cannot provide all-weather blood glucose values for diabetes patients. Diabetes patients also can not obtain the overall changes in blood glucose and the reasons for the changes, so they can not develop targeted sugar control programs in line with specific individuals, including diet, medication, exercise, etc.
Published: 2024-04-15
Pages: 110
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now